Buprenorphine Transdermal Delivery System: Bioequivalence Assessment and Adhesion Performance of Two Patch Formulations

<b>Background and Objective:</b> Buprenorphine is an opioid drug indicated for the management of severe and persistent pain. The buprenorphine transdermal patch provides a non-invasive method of rate-controlled drug release, ensuring constant and predictable drug plasma levels over an extended perio...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Marcelo Gomes Davanço, Miguel Fortuny, Alejandro Scasso, Jessica Meulman, Fernando Costa, Thalita Martins da Silva, Débora Renz Barreto Vianna, Leonardo de Souza Teixeira, Karini Bruno Bellorio, Ana Carolina Costa Sampaio, Celso Francisco Pimentel Vespasiano
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2024-09-01
Serija:	Pharmaceutics
Teme:	buprenorphine transdermal delivery system patch opioid bioequivalence adhesion
Online dostop:	https://www.mdpi.com/1999-4923/16/10/1249
Oznake:	Označite Brez oznak, prvi označite!